Answers are grounded in this paper and cite their sources.
Cell model study demonstrates successful generation and characterization of patient-derived iPSC lines from individuals with CLN3-related conditions, highlighting new platforms for disease modeling.
Primary fibroblasts from six individuals with CLN3-related conditions were used to generate induced pluripotent stem cell (iPSC) lines CHDTRi001-B, CHDTRi002-B, CHDTRi003-A, CHDTRi004-B, CHDTRi005-A, and CHDTRi006-E through the expression of four reprogramming factors: human OCT3/4, KLF4, SOX2, and c-MYC. The iPSC lines were characterized to confirm their pluripotency via immunocytochemistry, flow cytometry, and teratoma formation. Genomic stability, cell line identity, and CLN3 genotype were confirmed. These iPSC lines may be used as participant-derived experimental models for further investigation of CLN3, a rare, fatal, pediatric, blindness and neurodegenerative lysosomal disorder with no cure.
No takes yet. Share an insight, caveat, or question.
Dwojak et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: